Literature DB >> 16249227

Anchorage on fibronectin via VLA-5 (alpha5beta1 integrin) protects rheumatoid synovial cells from Fas-induced apoptosis.

A Kitagawa1, Y Miura, R Saura, M Mitani, H Ishikawa, A Hashiramoto, S Yoshiya, S Shiozawa, M Kurosaka.   

Abstract

BACKGROUND: Rheumatoid synovial cells are resistant to apoptosis induction in vivo, whereas, fibroblast-like synovial cells in rheumatoid arthritis (RA-FLS) are vulnerable to Fas-induced apoptosis in vitro.
OBJECTIVE: To clarify this discrepancy by studying the contribution of the interaction between cellular integrin and matrix fibronectin (Fn), which is significantly increased in the rheumatoid joints, to the induction of apoptosis in RA-FLS.
METHODS: Integrin and Fas mRNAs were measured by reverse transcription-polymerase chain reaction in RA-FLS. Integrins expressed in rheumatoid synovial tissues were analysed by immunohistochemistry. RA-FLS plated either on Fn or on control poly-L-lysine were incubated with agonistic anti-Fas monoclonal antibodies (mAbs). Apoptosis induction was evaluated using terminal deoxynucleotidyl transferase mediated UTP nick end labelling (TUNEL) and immunoblotting for caspase-3 and poly (ADP-ribose) polymerase in the presence or absence of anti-VLA-5 mAb.
RESULTS: VLA-5 (alpha5beta1 integrin), a major integrin expressed on RA-FLS, was required for the adhesion of RA-FLS on Fn. RA-FLS plated on Fn were more resistant to Fas-induced apoptosis than those plated on control poly-L-lysine. This protection by Fn was reversed by anti-VLA-5 mAb.
CONCLUSION: Anchorage of RA-FLS on matrix Fn via VLA-5 protects RA-FLS from Fas-induced apoptosis, and Fn abundantly present in rheumatoid synovium appears to afford RA-FLS resistance against apoptosis induction in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249227      PMCID: PMC1798166          DOI: 10.1136/ard.2005.041707

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  52 in total

Review 1.  Apoptosis in rheumatoid arthritis.

Authors:  Anja Baier; Ingmar Meineckel; Steffen Gay; Thomas Pap
Journal:  Curr Opin Rheumatol       Date:  2003-05       Impact factor: 5.006

2.  Adhesion to fibronectin via alpha4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas/Apo-1 receptors.

Authors:  M Garcia-Gila; E M Lopez-Martin; A Garcia-Pardo
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

3.  Differential expression pattern of the antiapoptotic proteins, Bcl-2 and FLIP, in experimental arthritis.

Authors:  H Perlman; H Liu; C Georganas; A E Koch; E Shamiyeh; G K Haines; R M Pope
Journal:  Arthritis Rheum       Date:  2001-12

4.  Beta 1 (CD29) integrin expression in rheumatoid synovial membranes: an immunohistologic study of distribution patterns.

Authors:  H el Gabalawy; J Wilkins
Journal:  J Rheumatol       Date:  1993-02       Impact factor: 4.666

5.  Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts.

Authors:  S Matsumoto; U Müller-Ladner; R E Gay; K Nishioka; S Gay
Journal:  J Rheumatol       Date:  1996-08       Impact factor: 4.666

6.  An immunohistochemical and immunoelectron microscopic study of adhesion molecules in synovial pannus formation in rheumatoid arthritis.

Authors:  H Ishikawa; S Hirata; Y Andoh; H Kubo; N Nakagawa; Y Nishibayashi; K Mizuno
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

7.  Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus.

Authors:  S Shiozawa; K Shiozawa; T Fujita
Journal:  Arthritis Rheum       Date:  1983-04

8.  Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes.

Authors:  T Nakajima; H Aono; T Hasunuma; K Yamamoto; T Shirai; K Hirohata; K Nishioka
Journal:  Arthritis Rheum       Date:  1995-04

9.  The role of adhesion molecules in synovial pannus formation in rheumatoid arthritis.

Authors:  H Ishikawa; S Hirata; Y Nishibayashi; S Imura; H Kubo; O Ohno
Journal:  Clin Orthop Relat Res       Date:  1994-03       Impact factor: 4.176

10.  Use of an Immobilized Monoclonal Antibody to Examine Integrin alpha5beta1 Signaling Independent of Cell Spreading.

Authors:  Wenjie Bao; Staffan Strömblad
Journal:  Biol Proced Online       Date:  2002-11-11       Impact factor: 3.244

View more
  6 in total

1.  Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis.

Authors:  Tatsuya Okada; Hiroto Tsukano; Motoyoshi Endo; Mitsuhisa Tabata; Keishi Miyata; Tsuyoshi Kadomatsu; Kazuya Miyashita; Kei Semba; Eiichi Nakamura; Michishi Tsukano; Hiroshi Mizuta; Yuichi Oike
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

2.  Attachment to laminin-111 facilitates transforming growth factor beta-induced expression of matrix metalloproteinase-3 in synovial fibroblasts.

Authors:  Maik Hoberg; Maximilian Rudert; Thomas Pap; Gerd Klein; Steffen Gay; Wilhelm K Aicher
Journal:  Ann Rheum Dis       Date:  2006-11-23       Impact factor: 19.103

3.  Vaccinia virus WR53.5/F14.5 protein is a new component of intracellular mature virus and is important for calcium-independent cell adhesion and vaccinia virus virulence in mice.

Authors:  Roza Izmailyan; Wen Chang
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

4.  Fas-mediated apoptosis is regulated by the extracellular matrix protein CCN1 (CYR61) in vitro and in vivo.

Authors:  Vladislava Juric; Chih-Chiun Chen; Lester F Lau
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

Review 5.  Integrins and their ligands in rheumatoid arthritis.

Authors:  Torsten Lowin; Rainer H Straub
Journal:  Arthritis Res Ther       Date:  2011-10-28       Impact factor: 5.156

6.  Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts.

Authors:  Ulf Müller-Ladner; Caroline Ospelt; Steffen Gay; Oliver Distler; Thomas Pap
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.